Product Information
ETHOSUXIMIDE 250 MG CAPSULE is a generic product labeled by Bionpharma Inc., priced at $0.2483 per EA under NDC 69452015220. Its NADAC has been published 492 times since Mar 22, 2017.
FDA first approved this application on Oct 28, 2002. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
250 mg/1
Manufacturer
Bionpharma Inc.NDC
69452015220
Classification
Generic
Dosage Form
CAPSULE, LIQUID FILLED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
ETHOSUXIMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA040430FDA Approved
10/28/2002
TE Code
AB
On Market Since
10/21/2016
Pharmacological Classes
Price Statistics
The NADAC for ETHOSUXIMIDE 250 MG CAPSULE has been published 492 times since Mar 22, 2017, and over the history we have for it it has declined 77.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2483 per EA |
|---|---|
| All-time high | $1.1198 (Apr 12, 2017) |
| All-time low | $0.1798 (Nov 20, 2024) |
| 52-week high | $0.2595 |
| 52-week low | $0.2210 |
| Median price | $0.5674 |
| Average price | $0.5582 |
| Largest weekly change | +76.6% (Jan 19, 2022) |
| Weeks tracked | 492 |
| Tracking since | Mar 22, 2017 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ETHOSUXIMIDE 250 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for ETHOSUXIMIDE 250 MG CAPSULE, manufactured by Bionpharma Inc., is $0.2483 per EA (NDC 69452015220), effective Aug 19, 2026.
How has the price of ETHOSUXIMIDE 250 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for ETHOSUXIMIDE 250 MG CAPSULE has declined 77.8%. It has been tracked across 492 weekly CMS publications since Mar 22, 2017.
What are the highest and lowest recorded NADAC prices for ETHOSUXIMIDE 250 MG CAPSULE?
Since Mar 22, 2017, the NADAC for ETHOSUXIMIDE 250 MG CAPSULE has ranged from a low of $0.1798 (Nov 20, 2024) to a high of $1.1198 (Apr 12, 2017), with a median of $0.5674 per EA.
Are there cheaper alternatives to ETHOSUXIMIDE 250 MG CAPSULE?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ETHOSUXIMIDE 250 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures ETHOSUXIMIDE 250 MG CAPSULE?
ETHOSUXIMIDE 250 MG CAPSULE (NDC 69452015220) is labeled by Bionpharma Inc., and CMS classifies it as a generic product.